Literature DB >> 31279158

Management of suspected and confirmed recurrent venous thrombosis while on anticoagulant therapy. What next?

Marc A Rodger1, Sebastien Miranda2, Aurelien Delluc2, Marc Carrier2.   

Abstract

Suspected recurrent venous thromboembolism (VTE) is a common and vexing clinical problem. Confounding the diagnosis of recurrent VTE is a high frequency of residual VTE from prior VTE. The diagnosis of recurrent VTE must be established by comparing current imaging with past imaging to distinguish acute from chronic thrombosis. Next, we must ascertain if non-compliance was the cause of "apparent therapeutic failure" and if non-compliance is at play then re-initiate anticoagulant therapy. Therapeutic failure is relatively uncommon. As such, we must consider underlying causes of therapeutic failures including malignancy and potent thrombophilias. Finally, short term anticoagulant management of therapeutic failures is controversial, and requires further research, but the best current evidence supports a course of full-dose low-molecular-weight heparin (LMWH) (and dose escalated LMWH if failure occurs while on full-dose LMWH).
Copyright © 2019 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Anticoagulant; Diagnosis; Treatment; Venous thromboembolism

Year:  2019        PMID: 31279158     DOI: 10.1016/j.thromres.2019.06.017

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  2 in total

1.  Anticoagulant therapy management of venous thromboembolism recurrence occurring during anticoagulant therapy: a descriptive study.

Authors:  Nhu Lai; Aubrey E Jones; Stacy A Johnson; Daniel M Witt
Journal:  J Thromb Thrombolysis       Date:  2021-01-23       Impact factor: 5.221

2.  The Clot Thickens: Diagnosing Acute Pulmonary Embolism as a Trigger for Chronic Obstructive Pulmonary Disease Exacerbation in the Setting of Anticoagulation Failure.

Authors:  Sameh N Saleh; Ishak A Mansi
Journal:  Eur J Case Rep Intern Med       Date:  2020-09-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.